Moreover, we demonstrated that CDK1-wildtype interacted with STAT3, while mutations CDK1-K33R or CDK1-K33Q both impeded the interaction with STAT3, resulting in reduced phosphorylation of STAT3, which caused the diminishment of cancer stemness. This evidence concerns the gene STAT3 and cancer.